echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Discover the real culprit of acute lymphocytic leukemia drug resistance and recurrence-thiopurines

    Discover the real culprit of acute lymphocytic leukemia drug resistance and recurrence-thiopurines

    • Last Update: 2021-07-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Acute lymphocytic leukemia (ALL) is a cancer of the bone marrow that produces too many lymphocytes, which can occur in children or adults


    The results of their research were published in the journal Nature Cancer


    The researchers wrote: "Chemotherapy is the standard treatment for pediatric ALL, and it sometimes relapses as a feature of chemotherapy resistance


    Dr.


    This discovery provides the first direct genomic and experimental evidence for childhood cancers that drug-resistant mutations can be induced by chemotherapy, but they do not always appear in the diagnosis


    Recurrence is still the leading cause of death in children and adolescents with ALL worldwide, although at St.


    The researchers analyzed more than 1,000 samples collected from the United States, China, and Germany


    Co-first author, Dr.


    "This research has not only changed our thinking about the treatment of ALL, but it has also opened the door to studying how defect repair produces drug-resistant mutations," Zhou said


    In the future, we may monitor the bone marrow during treatment to detect these mutation signals as early as possible to help identify high-risk patients.


    Chemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapse.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.